JDRF-funded research has helped to speed the progress of a drug called Lucentis to submission for approval in Europe.
News: December 2009
Find out the latest news about JDRF's research and fundraising events. If you are a journalist interested in learning more about JDRF and type 1 diabetes, please contact our Communications Team on 020 7713 2030 / 2036.
You can keep up to date with the latest JDRF news by signing up to our free e-newsletter. Click here to sign up.
.jpg)
End in sight for new treatment for diabetic eye disease (17/12/2009)
US approves first stem cell lines for research (03/12/2009)
US regulators have authorised the first human embryonic stem cells for use in medical research. The National Institutes of Health (NIH) yesterday approved a total of 13 lines of stem cells produced by scientists at the Children’s Hospital in Boston and Rackefeller University in New York. The...
.jpg)
